Effect of statins on gastric cancer incidence: A meta-Analysis of case control studies

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 4, 2014, Pages 859-865

  Ma, Zhiyuan ^a   Wang, Wenjin ^a   Jin, Guoyin ^b   Chu, Pei ^a   Li, Haitao ^c  

^a LANZHOU UNIVERSITY   (China)

^b HEBEI NORTH UNIVERSITY   (China)

^c Department of General Surgery   (China)

Author keywords

Case control study; gastric cancer; meta analysis; statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ASIA; CANCER INCIDENCE; CASE CONTROL STUDY; COCHRANE LIBRARY; DISEASE ASSOCIATION; DRUG EXPOSURE; EUROPE; FOLLOW UP; FULL TEXT DATABASE; HUMAN; HYPERCHOLESTEROLEMIA; META ANALYSIS; OBSERVATIONAL STUDY; REVIEW; STOMACH CANCER; TREATMENT DURATION; UNITED STATES; INCIDENCE; STOMACH NEOPLASMS;

CASE-CONTROL STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; STOMACH NEOPLASMS;

EID: 84921411412     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.138218     Document Type: Review

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62.
3. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50.
4. Degiuli M, Calvo F. Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary World J Surg 2006;30:2193-203.
5. Pozzo C, Barone C. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents Oncologist 2008;13:794-806.
6. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009;374:477-90.
7. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA 2010;303:1729-37.
8. Wagner Anna D, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, et al. Chemotherapy for advanced gastric cancer. Cochrane Database of Systematic Reviews 2010:CD004064.
9. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 2008;372:392-7.
10. Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: Results from a cohort study and a meta-analysis. Br J Cancer 2009;100:551-7.
11. Epplein M, Nomura AM, Wilkens LR, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: The multiethnic cohort study. Am J Epidemiol 2009;170:507-14.
12. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
13. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: A systematic review and meta-analysis. J Natl Cancer Inst 2003;95:1784-91.
14. Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Aspirin use and the risk of gastric cancer: A meta-analysis. Dig Dis Sci 2010;55:1533-9.
15. Walley T, Folino-Gallo P, Schwabe U, van Ganse E; EuroMedStat Group. Variations and increase in use of statins across Europe: Data from administrative databases. BMJ 2004;328:385-6.
16. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.
17. Zhou X, Du JL, Yuan J, Chen YQ. Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: A meta-analysis. Int J Med Sci 2013;10:198-205.
18. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2013: CD004816.
19. Browning DR, Martin RM. Statins and risk of cancer: A systematic review and metaanalysis. Int J Cancer 2007;120:833-43.
20. Kuoppala J, LamminpaäÄ, Pukkala E. Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 2008;44:2122-32.
21. Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, et al. Cholesterol Treatment Trialists' (CTT) Collaboration. Lack of effect of lowering LDL cholesterol on cancer: Meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 2012;7:e29849.
22. Shimoyama S. Statins and gastric cancer risk. Hepatogastroenterology 2011;58:1057-61.
23. Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to statins and risk of common cancers: A series of nested case-control studies. BMC Cancer 2011;11:409.
24. Chiu HF, Ho SC, Chang CC, Wu TN, Yang CY. Statins are associated with a reduced risk of gastric cancer: A population-based case-control study. Am J Gastroenterol 2011;106:2098-103.
25. Leung HW, Chan AL, Lo D, Leung JH, Chen HL. Common cancer risk and statins: A population-based case-control study in a Chinese population. Exp Opin Drug Saf 2013;12:19-27.
26. Cochran WG. The combination of estimate from different experiments. Biometrics 1954;10:101-29.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
28. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. Available from: http://ims.cochrane.org/revman/download. [Last accessed on 2012].
29. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ. The risk of cancer in users of statins. J Clin Oncol 2004;22:2388-94.
30. Lee J, Lee SH, Hur KY, Woo SY, Kim SW, Kang WK. Statins and the risk of gastric cancer in diabetes patients. BMC Cancer 2012;12:596.
31. Lai SW, Liao KF, Lin CY, Lin CL, Sung FC. Statins on the risk of gastric cancer: A population-based observation in Taiwan. Am J Gastroenterol 2013;108:147-9.
32. Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer 2004;90:635-7.
33. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: A meta-analysis. JAMA 2006;295:74-80.
34. Bonovas S, Filioussi K, Flordellis CS, Sitaras NM. Statins and the risk of colorectal cancer: A meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007;25:3462-8.
35. Bardou M, Barkun A, Martel M. Effect of statin therapy on colorectal cancer. Gut 2010;59:1572-85.
36. Taylor ML, Wells BJ, Smolak MJ. Statins and cancer: A meta-analysis of case-control studies. Eur J Cancer Prev 2008;17:259-68.
37. Cheng MH, Chiu HF, Ho SC, Tsai SS, Wu TN, Yang CY. Statin use and the risk of colorectal cancer: A population-based case-control study. World J Gastroenterol 2011;17:5197-202.
38. Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, et al. Statins and primary liver cancer: A meta-analysis of observational studies. Eur J Cancer Prev 2012;22:229-34.
39. Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and meta-analysis. Gastroenterology 2012;144:323-32.
40. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
41. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.
42. Ford AC. Chemoprevention for gastric cancer. Best Pract Res Clin Gastroenterol 2011;25:581-92.